SAL0140 study for primary aldosteronism and high blood pressure
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with primary aldosteronism
- Your systolic blood pressure (top number) is at least 145 mmHg when measured in the office
- You are already taking stable blood pressure medications
- Your blood potassium level is between 3.0 and 5.0 mmol/L
- You agree to use birth control during the study if you can become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication for primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. The goal is to see if it helps control blood pressure better than the current standard of care.
This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.
This trial looks for better ways to diagnose primary aldosteronism (PA), a common cause of high blood pressure that can be treated. It may help find people whose hypertension is caused by this condition so they can get the right treatment sooner.
This study tests a new medication (QLS1410) for primary aldosteronism, a condition where the body produces too much of a hormone called aldosterone, causing high blood pressure. The trial will see if this drug can help control blood pressure better than current treatments.
This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.
This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.